Ultragenyx Pharmaceutical Inc.
RARE
RARE: Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
moreShow RARE Financials
Recent trades of RARE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RARE's directors and management
Government lobbying spending instances
-
$60,000 Jul 16, 2023 Issue: Health Issues
-
$50,000 Apr 17, 2023 Issue: Health Issues
-
$50,000 Jan 17, 2023 Issue: Health Issues
-
$50,000 Oct 17, 2022 Issue: Health Issues
-
$50,000 Jul 17, 2022 Issue: Health Issues
-
$50,000 Apr 17, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: Pharmacy Health Issues
-
$50,000 Jan 18, 2022 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues Pharmacy
-
$50,000 Oct 19, 2021 Issue: Health Issues
-
$45,000 Jul 20, 2021 Issue: Health Issues
-
$20,000 Jul 19, 2021 Issue: Health Issues
-
$50,000 Jul 18, 2021 Issue: Health Issues
-
$50,000 Apr 20, 2021 Issue: Pharmacy Health Issues
-
$50,000 Apr 20, 2021 Issue: Health Issues
-
$10,000 Apr 19, 2021 Issue: Health Issues
-
$50,000 Jan 21, 2021 Issue: None
-
$40,000 Jan 20, 2021 Issue: Budget/Appropriations Health Issues
-
$20,000 Oct 20, 2020 Issue: Pharmacy Health Issues
-
$50,000 Oct 20, 2020 Issue: Budget/Appropriations Health Issues
-
$50,000 Jul 20, 2020 Issue: Pharmacy
-
$40,000 Jul 19, 2020 Issue: Health Issues
-
$10,000 Apr 20, 2020 Issue: Pharmacy
-
$40,000 Apr 20, 2020 Issue: Health Issues
-
$40,000 Jan 20, 2020 Issue: Health Issues
New patents grants
Federal grants, loans, and purchases
Followers on RARE's company Twitter account
Number of mentions of RARE in WallStreetBets Daily Discussion
Recent insights relating to RARE
Recent picks made for RARE stock on CNBC
ETFs with the largest estimated holdings in RARE
Flights by private jets registered to RARE